Elecoglipron

N/A

Report date: 2026/04/17 20:02:02
NME

Base Information

Drug NameElecoglipron
Drug Alias NameECC-5004AZD5004AZD-5004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSlovakia +[12] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesEccogene (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEccogene (Shanghai) Co LtdEccogene IncAstrazeneca Plc +[4] 
Inactive CompaniesN/A
Active IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A